![D. Grayson Allen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D.
Grayson Allen is currently the Chief Operating Officer, CFO & Director at RevBio, Inc. He previously worked as a Principal at Citizens Capital Markets, Inc. Allen is a graduate of Dartmouth College.
| Companies | Position | Start |
|---|---|---|
RevBio, Inc.
 RevBio, Inc. Medical SpecialtiesHealth Technology Manufactures dental, cranial, trauma,spinal and animal health treatment medical devices | Director of Finance/CFO | - |
| Companies | Position | End |
|---|---|---|
Citizens Capital Markets, Inc.
 Citizens Capital Markets, Inc. Investment ManagersFinance Citizens Capital Markets invests in companies located in the United States, with revenues of USD 15 - 250 million and an EBITDA of USD 3 million for mezzanine investments. The firm focuses on sectors such as business services, technology, software, consumer products, distributors and manufacturers. It participates in mezzanine, growth, buyouts and recapitalization capital requirements with an investment size of USD 3 - 15 million for subordinated debt investments and USD 1 - 3 million for growth equity investments. It makes co-investments and also takes a seat on the board of directors. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Citizens Capital Markets, Inc.
Citizens Capital Markets, Inc. Investment ManagersFinance Citizens Capital Markets invests in companies located in the United States, with revenues of USD 15 - 250 million and an EBITDA of USD 3 million for mezzanine investments. The firm focuses on sectors such as business services, technology, software, consumer products, distributors and manufacturers. It participates in mezzanine, growth, buyouts and recapitalization capital requirements with an investment size of USD 3 - 15 million for subordinated debt investments and USD 1 - 3 million for growth equity investments. It makes co-investments and also takes a seat on the board of directors. | Finance |
RevBio, Inc.
RevBio, Inc. Medical SpecialtiesHealth Technology Manufactures dental, cranial, trauma,spinal and animal health treatment medical devices | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
